These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22010784)

  • 1. Renal microvascular disease predicts renal function in diabetes.
    Futrakul N; Futrakul P
    Ren Fail; 2012; 34(1):126-9. PubMed ID: 22010784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced peritubular capillary flow and renal function can be accomplished in normoalbuminuric type 2 diabetic nephropathy.
    Futrakul N; Kulaputana O; Futrakul P; Chavanakul A; Deekajorndech T
    Ren Fail; 2011; 33(3):312-5. PubMed ID: 21401356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal microvascular disease in an aging population: a reversible process?
    Futrakul N; Futrakul P
    Ren Fail; 2008; 30(4):353-6. PubMed ID: 18569906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal perfusion and disease progression.
    Sensirivatana R; Kingwatanakul P; Futrakul P
    J Med Assoc Thai; 1999 May; 82(5):496-505. PubMed ID: 10443100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubular dysfunction and hemodynamic alteration in normoalbuminuric type 2 diabetes.
    Futrakul N; Vongthavarawat V; Sirisalipotch S; Chairatanarat T; Futrakul P; Suwanwalaikorn S
    Clin Hemorheol Microcirc; 2005; 32(1):59-65. PubMed ID: 15665427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes.
    Futrakul N; Futrakul P
    Int J Vasc Med; 2011; 2011():971524. PubMed ID: 21748023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered vascular homeostasis in type 2 diabetic nephropathy.
    Futrakul N; Butthep P; Futrakul P
    Ren Fail; 2009; 31(3):207-10. PubMed ID: 19288326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats.
    Bilan VP; Salah EM; Bastacky S; Jones HB; Mayers RM; Zinker B; Poucher SM; Tofovic SP
    J Endocrinol; 2011 Sep; 210(3):293-308. PubMed ID: 21680617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early stage of vascular disease and diabetic kidney disease: an under-recognized entity.
    Futrakul N; Chanakul A; Futrakul P; Deekajorndech T
    Ren Fail; 2015; 37(8):1243-6. PubMed ID: 26365595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endothelin and endothelin receptor antagonists in renal disease.
    Neuhofer W; Pittrow D
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance in diabetic nephropathy--cause or consequence?
    Svensson M; Eriksson JW
    Diabetes Metab Res Rev; 2006; 22(5):401-10. PubMed ID: 16703644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy.
    Rosolowsky ET; Niewczas MA; Ficociello LH; Perkins BA; Warram JH; Krolewski AS
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S46-53. PubMed ID: 18849087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of chronic renal disease and diabetic nephropathy: a review of clinical studies and current therapy.
    Marinides GN
    J Med; 1993; 24(4-5):266-88. PubMed ID: 8258740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anemia in diabetic nephropathy: prevalence, clinical and pathophysiological aspects].
    Shestakova MV; Martynov SA; Il'in AV; Kniazeva AP; Shamkhalova MSh; Trubitsyna NP
    Ter Arkh; 2008; 80(6):41-7. PubMed ID: 18655475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis.
    Jerums G; Panagiotopoulos S; Premaratne E; Power DA; MacIsaac RJ
    Am J Nephrol; 2008; 28(4):614-27. PubMed ID: 18285683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albuminuria and diabetic nephropathy.
    Chang SS
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():974-9. PubMed ID: 18806713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of endothelial injury and dysfunction in conjunction with correction of hemodynamic maladjustment can effectively restore renal function in type 2 diabetic nephropathy.
    Futrakul N; Butthep P; Vongthavarawat V; Futrakul P; Sirisalipoch S; Chaivatanarat T; Suwanwalaikorn S
    Clin Hemorheol Microcirc; 2006; 34(3):373-81. PubMed ID: 16614461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal histological lesions in patients with type II diabetes mellitus].
    Castellano I; Covarsí A; Novillo R; Gómez-Martino JR; Ferrando L
    Nefrologia; 2002; 22(2):162-9. PubMed ID: 12085417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal microvascular changes in streptozotocin-induced, long-termed diabetic rat.
    Sricharoenvej S; Tongpob Y; Lanlua P; Piyawinijwong S; Roongruangchai J; Phoungpetchara I
    J Med Assoc Thai; 2007 Dec; 90(12):2677-82. PubMed ID: 18386720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.